U.S. health officials finalized guidelines for infant formula makers that aim to ensure products meet certain quality controls to keep them safe.» Read More
NEW YORK— A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:. Panhandle Royalty Co. rose 13.9 percent to $60.72. URS Corp. rose 11.8 percent to $58.16.
Medical technology group Medtronic Inc said last month that it plans to buy Covidien Plc, a rival based in low-tax Ireland. The research service said other inversions have been done in the past decade by Mallinckrodt Pharmaceuticals, Perrigo Co Plc, Actavis Plc and other companies, many of them rebasing for tax purposes to Ireland.
NEW YORK, June 27- Mathew Martoma, a former SAC Capital Advisors portfolio manager convicted of insider trading, should be sentenced to a "substantial" term of prison beyond the eight years recommended by probation officers, U.S. prosecutors argued Friday. In court papers filed in New York federal court, prosecutors urged U.S.
Mead Johnson Nutrition Co in 2011 saw its shares fall when stores pulled some powdered versions of its Enfamil product over concerns about infection, although the FDA later said a recall was not needed. The new rule, the FDA said, is aimed at establishing "good manufacturing practices" that many companies have already adopted voluntarily.
In total, SAC Capital has agreed to pay $1.8 billion to resolve criminal and civil probes into insider trading. SAC Capital also agreed to be placed on probation for five years, and employ a compliance consultant, former federal prosecutor Bart Schwartz.
In total, SAC Capital has agreed to pay $1.8 billion to resolve criminal and civil probes into insider trading. SAC Capital also agreed to be placed on probation for five years, and employ a compliance consultant, former federal prosecutor Bart Schwartz. The sentencing marks the end of an era for SAC Capital, which by last year had managed $15 billion of assets.
WASHINGTON, March 28- The U.S. Federal Trade Commission seeks a settlement of $1 billion or more from pharmaceutical companies it has sued for delaying the sale of cheaper medicines after patents on brand-name drugs may have expired, an FTC official told a legal conference on Friday.
A couple of stocks stand to gain over the next two weeks, Paul Hickey of Bespoke Investment Group says.
DUBLIN, March 10- U.S. fruit firm Chiquita Brands and Irish rival Fyffes, Europe's largest distributor, have struck an all-stock merger deal to create the world's biggest banana supplier. The global banana market is controlled by four multinationals, according to the United Nations: Chiquita, Fresh Del Monte, Hawaii-founded Dole Food Company and Fyffes.
DUBLIN, March 10- U.S. fruit distributor Chiquita Brands International Inc is to buy Irish rival Fyffes Plc in an all-stock deal valued at $526 million to create the world's biggest banana supplier.
Events in Ukraine appear to be improving, but it may only be a matter of time before they take another turn for the worse. Are you prepared?
In his book "Get Rich Carefully," CNBC's "Mad Money" host explains how spotting long-term megatrends can help investors surf the wave of profitability.
Cramer believes there’s always opportunity in the market. You simply have to know where to look.
Perrigo CEO Joseph Papa provides insight on the current flu season, and how it plans on getting its name better known.
Perrigo CEO Joseph Papa discusses how its new headquarters in Ireland will impact its tax structure, and whether the company will add a dividend.
Jim Cramer has been a fan of this company for quite some time. But a good stock always needs new catalysts.
Investing is a bit like an Ellery Queen mystery. If you can follow the clues you should find what you're seeking - upside.
More large American corporations are reducing their tax bill by buying a foreign company and effectively renouncing their United States citizenship.
The Mad Money host always suggests watching for dips. But is the weakness in Perrigo really a buying opportunity?
Uncertainty about the Fed is making stocks nervous and is adding to a growing bearishness about the market.